Xiao-Han Yuan

发表

Discovery of tofacitinib derivatives as orally active antitumor agents based on the scaffold hybridization strategy.

Xiao-Jing Shi, Hong-min Liu, Xiao-Jing Li, 2020, European journal of medicinal chemistry.

Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators.

Mengru Wang, Zhe-Sheng Chen, Linlin Yang, 2020, Journal of medicinal chemistry.

Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1/KDM1A inhibitors.

Hong-min Liu, Bin Yu, Shuai Wang, 2019, European journal of medicinal chemistry.

HFIP-promoted catalyst-free cascade reactions for the synthesis of biologically relevant 3,3-di(indolyl)indolin-2-ones from indoles and isatins

Hong-min Liu, Bin Yu, Shuai Wang, 2020 .

Discovery of [1,2,4]triazolo[1,5-a]pyrimidines derivatives as potential anticancer agents.

Wen-en Zhao, Hong-min Liu, Jin-ling Huo, 2020, European journal of medicinal chemistry.

FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application.

Sai-Qi Wang, Xiao-Bing Chen, Bin Yu, 2021, European journal of medicinal chemistry.

Discovery of new [1,2,4] Triazolo[1,5-a]Pyrimidine derivatives that Kill gastric cancer cells via the mitochondria pathway.

Hong-min Liu, Bin Yu, Shuai Wang, 2020, European journal of medicinal chemistry.

Synthesis of Natural Product-Like Tricyclic Higher-Carbon Sugar Nucleosides

Hong-min Liu, Bin Yu, Shuai Wang, 2021, Pharmaceutical Fronts.

Drug repurposing: Discovery of troxipide analogs as potent antitumor agents

Hong-min Liu, Jin-ling Huo, Shuai Wang, 2020, European Journal of Medicinal Chemistry.

Experience-based discovery (EBD) of aryl hydrazines as new scaffolds for the development of LSD1/KDM1A inhibitors.

Linlin Yang, Hong-min Liu, Bin Yu, 2019, European journal of medicinal chemistry.